Fosun Pharma provides guarantees for subsidiaries

Shanghai Fosun Pharmaceutical Group (SSE:600196) has announced it is providing guarantees for its subsidiaries. The guarantees include several agreements. One guarantee involves its subsidiary, Jianjia Medical, and its subsidiary, Jianjia Rehabilitation, providing a guarantee for Shanghai Jianyuan's financing lease business with Haitong Hengxin, involving a total rental amount of CNY 10.2459 million. A further guarantee involves Jianjia Medical providing a guarantee for financing obtained by Hangzhou Zhongxing Hospital and Shantou Jianjia from Bank of Communications, up to CNY 22 million and CNY 5.5 million respectively. Fosun Pharma itself is providing a guarantee for Fosun Health's CNY 100 million comprehensive credit line with China Minsheng Bank. Further, Fosun Diagnostics is providing a guarantee for its subsidiary, Changsha Fosun Diagnostics, for financing of CNY 15 million from Hunan Bank. Finally, Fosun Pharma is guaranteeing financing of up to CNY 700 million equivalent in other currencies with Standard Chartered Bank for Fosun Pharma Industry. As of April 3, 2025, the total actual guarantee amount for Shanghai Jianyuan is CNY 52.2459 million, Hangzhou Zhongxing Hospital is CNY 22 million, Shantou Jianjia is CNY 20.623 million, Fosun Health is CNY 203.295 million, Changsha Fosun Diagnostics is CNY 16.5 million, and Fosun Pharma Industry is CNY 891.098 million.